Is Shah Capital’s Criticism of Novavax Fair? A Wall Street Analyst Weighs In
In May 2024, Shah Capital, a hedge fund in North Carolina, withdrew from its proxy fight against Novavax’s…
Global drug makers face pricing pressure as China targets affordable healthcare
Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial – Endpoints News
Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial Endpoints News Roche unveils data behind BTK inhibitor’s phase…
Exclusive-US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
Jan 15 (Reuters) – The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for…
SNY & REGN’s Dupixent Gets EU Nod for Chronic Spontaneous Urticaria
Sanofi SNY and partner Regeneron REGN announced that the European Commission has approved Dupixent (dupilumab) for the treatment of…
China’s importers sign record US$83.5 billion in deals at CIIE after US-China trade truce
Chinese companies signed a record US$83.5 billion in import deals at the China International Import Expo (CIIE) in…